Basic Information
Passage Bio is a gene therapy company currently focused on the development of five drugs for treating monogenic central nervous system diseases. Headquartered in Philadelphia, Pennsylvania, the company has established cooperative agreements with the University of Pennsylvania and the Orphan Disease Center (ODC).
Passage Bio Inc.
Philadelphia,Pennsylvania,United States of America
less than 15 people
January 01, 2018
patientservices@passagebio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios